Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Tencent Music Entertainment Group - ADR — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Tencent Music Entertainment Group - ADR trades at $8.38 (market cap $12.83B). The key difference: Halozyme Therapeutics Inc. Common Stock and Tencent Music Entertainment Group - ADR are close in size by market cap, and Tencent Music Entertainment Group - ADR pays a 3.02% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Tencent Music Entertainment Group - ADR for 67 Days on average.
| HALO | TME | |
|---|---|---|
Market Cap | $12.58B | $12.83B |
Volume | 2,179,278 | 3,618,478 |
Sector | Health | Media |
52-Week High | $115.22 | $23.71 |
52-Week Low | $61.63 | $7.74 |
Typical Hold Time | 1 Days | 67 Days |
Enterprise Value | $14.49B | $10.77B |
Dividend Yield | — | 3.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tencent Music Entertainment (TME) trades at $7.96, down 0.38% on the day, with a bearish technical signal despite strong fundamentals. The company reported robust revenue growth to $32.9B in 2025 and net income of $11.06B, with improving profit margins. Recent developments include a $1B notes offering and a $400M share repurchase program, reflecting financial discipline. Analyst consensus is mixed with 41.7% buy ratings but a $12.50 price target suggesting significant upside from current levels.
TME presents a compelling value opportunity with attractive valuation multiples (P/E 9.33, P/S 2.46) and strong profitability metrics. However, investors face risks from intense competition, regulatory oversight in China, and recent earnings misses. The stock's current discount to analyst targets offers potential upside, but requires monitoring of user growth trends and competitive pressures from short-form video platforms.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
